CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Peanut SLIT +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00597727
NCT00597727Phase 2Completed
CompareCT.gov

A Double-blinded, Placebo-controlled Study of Peanut Sublingual Immunotherapy in Children - DBPC Peanut SLIT

University of North Carolina, Chapel Hill·interventional·Posted Jan 18, 2008·Updated Mar 27, 2018

In Brief

A Phase 2 clinical trial evaluating Peanut SLIT and Placebo SLIT for Food Hypersensitivity. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The specific aim of this study is to determine if peanut allergen-specific SLIT will cause clinical desensitization and tolerance to develop in peanut-allergic young children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFood Hypersensitivity
CountriesUnited States
CollaboratorsNational Center for Complementary and Integrative Health (NCCIH)

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 18, 2008
Enrollment StartJan 1, 2008
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8.2 yearsPosted 18.5 years ago

Interventions

Peanut SLITdrug

Liquid peanut protein drops diluted in glycerin which are dosed under the tongue.

Placebo SLITdrug

Liquid glycerin without peanut which are dosed under the tongue.